Subcommittee on Health Chair Brett Guthrie (R-KY) and House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) have announced a hearing titled “Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices.” The purpose of the hearing is to emphasize the importance of the FDA in guiding safe and effective treatments and medical devices while ensuring transparency to rebuild public trust in government health agencies.
The hearing will take place on Wednesday, May 22, 2024, at 10:30 AM ET at 2322 Rayburn House Office Building. Dr. Patrizia Cavazzoni from the Center for Drug Evaluation and Research (CDER), Dr. Peter Marks from the Center for Biologics Evaluation and Research (CBER), and Dr. Jeffrey Shuren from the Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration will be among the witnesses present.
The notice is provided under the direction of the chair, and it is open to both public viewing and press coverage. Additionally, it will be live streamed online at https://energycommerce.house.gov/. For any questions or concerns regarding this event, you can contact Emma Schultheis with the Committee staff at Emma.Schultheis@mail.house.gov or Christopher Krepich with press-related inquiries at Christopher.Krepich@mail.house.gov
